Impact Analysis of Covid-19
The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
In recent years, non-radioactive nucleic acid labeling and detection methodologies have become available in response to a desire by researchers and their institutions to move away from the use of radioisotopes. Advancements made in the areas of chemiluminescence and fluorescence have allowed for an easier transition. In non-radioactive assays, signal is generated through an enzymatic reaction with a chemiluminescent or chromogenic substrate; alternatively, detection can occur through the appropriate excitation and emission of a fluorophore-labeled probe.
Scope of the Report:
The classification of non-radioactive nucleic acid labeling product includes biotin, DIG system, fluorescent and others. The proportion of DIG system in 2017 is about 33%, and the proportion is in increasing trend from 2013 to 2017.
Non-radioactive nucleic acid labeling product is widely used in DNA labeling, RNA labeling and oligonucleotide labeling. The most proportion of non-radioactive nucleic acid labeling product is used for DNA labeling, and the proportion in 2017 is about 56%.
United States is the largest sales place, with a sales market share nearly 43.73% in 2017. Following United States, Europe is the second largest Sales place with the Sales market share of 26.79%.
The worldwide market for Non-Radioactive Nucleic Acid Labeling Product is expected to grow at a CAGR of roughly 7.5% over the next five years, will reach 370 million US$ in 2024, from 240 million US$ in 2019, according to a new WMR study.
This report focuses on the Non-Radioactive Nucleic Acid Labeling Product in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Thermo Fisher Scientific
New England Biolabs
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Market Segment by Applications, can be divided into
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Non-Radioactive Nucleic Acid Labeling Product product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Non-Radioactive Nucleic Acid Labeling Product, with price, sales, revenue and global market share of Non-Radioactive Nucleic Acid Labeling Product in 2017 and 2018.
Chapter 3, the Non-Radioactive Nucleic Acid Labeling Product competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Non-Radioactive Nucleic Acid Labeling Product breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Non-Radioactive Nucleic Acid Labeling Product market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Non-Radioactive Nucleic Acid Labeling Product sales channel, distributors, customers, research findings and conclusion, appendix and data source.